Phase I Study of the Selective Aurora A Kinase Inhibitor MLN8054 in Patients with Advanced Solid Tumors: Safety, Pharmacokinetics, and Pharmacodynamics (Q58614732)
Jump to navigation
Jump to search
scientific article published on 19 August 2010
Language | Label | Description | Also known as |
---|---|---|---|
English | Phase I Study of the Selective Aurora A Kinase Inhibitor MLN8054 in Patients with Advanced Solid Tumors: Safety, Pharmacokinetics, and Pharmacodynamics |
scientific article published on 19 August 2010 |
Statements
Phase I study of the selective Aurora A kinase inhibitor MLN8054 in patients with advanced solid tumors: safety, pharmacokinetics, and pharmacodynamics (English)
Teresa Macarulla
Andres Cervantes
Elena Elez
Edith RodrÃguez-Braun
José Baselga
Gemma Sala
Inma Blasco
Hadi Danaee
Yih Lee
Jeffrey Ecsedy
Vaishali Shinde
Arijit Chakravarty
Douglas Bowman
Hua Liu
Howard Fingert
19 August 2010